The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.
Hooman KamelW T LongstrethDavid L TirschwellRichard A KronmalJoseph P BroderickYuko Y PaleschCaitlyn MeinzerCatherine DillonIrene EwingJudith A SpilkerMarco R Di TullioEldad A HodElsayed Z SolimanSeemant ChaturvediClaudia S MoyScott JanisMitchell Sv ElkindPublished in: International journal of stroke : official journal of the International Stroke Society (2018)
ARCADIA is the first trial to test whether anticoagulant therapy reduces stroke recurrence in patients with atrial cardiopathy but no known atrial fibrillation.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- heart failure
- clinical trial
- percutaneous coronary intervention
- study protocol
- phase iii
- phase ii
- randomized controlled trial
- stem cells
- mesenchymal stem cells
- subarachnoid hemorrhage
- free survival
- bone marrow
- mitral valve
- acute coronary syndrome
- cell therapy
- drug induced